Latest Regulatory News

Dimerix has secured a significant licensing agreement with Amicus Therapeutics for its kidney disease drug candidate DMX-200 in the US, receiving a US$30 million upfront payment and advancing its Phase 3 trial with FDA endorsement of a key clinical endpoint.

Stockland updates its interim dividend for the six months ending June 2025, confirming an estimated payout of AUD 0.172 per security and announcing the Dividend Reinvestment Plan price at AUD 5.43 with a 1% discount.

Mithril Silver and Gold Limited has successfully closed a C$11.5 million brokered private placement, positioning the company to advance its Copalquin district project in Mexico while bolstering working capital.

Barton Gold Holdings has completed the acquisition rights for the Wudinna Gold Project, adding 279,000 ounces of gold to its South Australian portfolio and raising its total resources to 2.14 million ounces. The deal, approved by Cobra Resources shareholders, positions Barton for regional growth pending final tenement transfers.

Tivan Limited has identified three new copper mineralisation sites at its Turiscai Project in Timor-Leste, advancing its early-stage exploration with assay results expected in September 2025.

Singular Health has landed a pivotal $2 million US pilot contract with Provider Network Solutions and completed an $8 million capital raise, advancing its medical imaging platform’s regulatory and product development milestones.

Newmont Corporation reported a robust second quarter in 2025, driven by higher gold prices, successful divestitures of non-core assets, and strong operational performance, reinforcing its financial strength and strategic focus.

The Commerce Commission has issued a Statement of Issues regarding Viridian NZ Bidco’s proposed acquisition of Metro Glass, highlighting potential competition risks in New Zealand’s glass processing and installation markets.

Pursuit Minerals has issued over 8.5 million placement options and additional shares to directors following shareholder approval, setting the stage for potential capital inflows through option exercises by mid-2027.

Peak Rare Earths Limited has updated its acquisition scheme, replacing Ganzhou Chenguang with Shenghe Resources (Singapore) Pte. Ltd. as the acquiring party, simplifying regulatory hurdles and valuing the company at nearly A$158 million.

Echo IQ has secured a strategic collaboration with the Mayo Clinic Platform and raised $17.3 million, advancing its AI-driven cardiology tools towards FDA clearance and US commercial scale.

Black Rock Mining Limited has launched a prospectus offering over 108 million unquoted options to participants of a recent $5 million placement, aiming to support the development of its Mahenge Graphite Project in Tanzania.